Abstract
Background Endothelial (EMPs) and platelet microparticles (PMPs) have been studied as biomarkers in several inflammatory diseases and as central players in intercellular communication. Methods In this cross-sectional study, we aimed to assess microparticle levels in asthma. Circulating microparticles and inflammatory and angiogenic markers were assessed by clinical and laboratorial evaluation, flow cytometry, and immunoassays, in a group of 20 asthmatic and 15 nonasthmatic subjects. Results Circulating levels of PMPs (either CD31+/42b+ or CD31+/42b+/AnV+) were significantly increased in asthmatics (P = 0.021) even after adjustment for confounders. Apoptotic EMPs (CD31+/42b - /AnV+) were significantly increased before (P = 0.005) but not after adjustments (P = 0.117). Conclusions We propose that PMPs may be putative asthma biomarkers, playing a role in asthma pathophysiology.
Original language | English |
---|---|
Pages (from-to) | 1073-1075 |
Number of pages | 3 |
Journal | Allergy: European Journal of Allergy and Clinical Immunology |
Volume | 68 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2013 |
Externally published | Yes |
Keywords
- apoptosis
- asthma
- endothelial and platelet microparticles
- sICAM-1
- VEGF